Patents by Inventor Michael Ploch

Michael Ploch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,8-CINEOLE CONTAINING COMPOSITION FOR THERAPEUTIC USE
    Publication number: 20240041821
    Abstract: The present invention relates to an active ingredient and a drug or composition, respectively, for use in reducing pathogenic germs in the human intestine or for use in reducing colonization of the human intestine with pathogenic germs, preferentially for the purpose of preventing, reducing or curing inflammatory diseases or preferentially for the purpose of prophylactic or therapeutic treatment of inflammatory diseases of the human body.
    Type: Application
    Filed: October 1, 2021
    Publication date: February 8, 2024
    Inventors: Michael PLOCH, Ralph PRIES, Karl-Ludwig BRUCHHAGE
  • NEW THERAPY CONCEPT FOR THE TREATMENT OF CORONA INFECTIONS, ESPECIALLY COVID-19 INFECTIONS
    Publication number: 20230414557
    Abstract: The present invention relates to the medical-pharmaceutical field of therapy of viral infections or viral diseases caused by corona viruses, especially COVID-19; especially, the present invention relates to an active ingredient and a drug or medicament containing said active ingredient for use in such therapy.
    Type: Application
    Filed: October 6, 2021
    Publication date: December 28, 2023
    Inventor: Michael PLOCH
  • Plants extracts and the use thereof
    Publication number: 20050208156
    Abstract: The invention relates to the novel use of plants and plant extracts for treating schizophrenia. Said plants and plant extracts are selected from St John's wort, gingko, saffron and ginseng. The use of said substances occurs preferably in conjunction with conventional psychotherapeutic drugs, i.e. in the form of a preparation combining standard medicaments for treating schizophrenia for the simultaneous, separate or graduated use in case of schizophrenia. The invention also relates to methods for treating schizophrenia.
    Type: Application
    Filed: March 25, 2003
    Publication date: September 22, 2005
    Applicant: Lichtwer Pharma GmbH
    Inventors: Michael Ploch, Harald Murck, Thomas Haffner